1. Home
  2. VSCO vs XENE Comparison

VSCO vs XENE Comparison

Compare VSCO & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSCO
  • XENE
  • Stock Information
  • Founded
  • VSCO 1977
  • XENE 1996
  • Country
  • VSCO United States
  • XENE Canada
  • Employees
  • VSCO N/A
  • XENE N/A
  • Industry
  • VSCO Clothing/Shoe/Accessory Stores
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSCO Consumer Discretionary
  • XENE Health Care
  • Exchange
  • VSCO Nasdaq
  • XENE Nasdaq
  • Market Cap
  • VSCO 2.8B
  • XENE 2.9B
  • IPO Year
  • VSCO N/A
  • XENE 2014
  • Fundamental
  • Price
  • VSCO $35.71
  • XENE $39.99
  • Analyst Decision
  • VSCO Hold
  • XENE Strong Buy
  • Analyst Count
  • VSCO 12
  • XENE 10
  • Target Price
  • VSCO $29.50
  • XENE $52.90
  • AVG Volume (30 Days)
  • VSCO 2.2M
  • XENE 784.7K
  • Earning Date
  • VSCO 12-04-2025
  • XENE 11-03-2025
  • Dividend Yield
  • VSCO N/A
  • XENE N/A
  • EPS Growth
  • VSCO 6.76
  • XENE N/A
  • EPS
  • VSCO 1.86
  • XENE N/A
  • Revenue
  • VSCO $6,265,000,000.00
  • XENE $7,500,000.00
  • Revenue This Year
  • VSCO $4.45
  • XENE N/A
  • Revenue Next Year
  • VSCO $2.75
  • XENE $207.88
  • P/E Ratio
  • VSCO $19.05
  • XENE N/A
  • Revenue Growth
  • VSCO 2.29
  • XENE N/A
  • 52 Week Low
  • VSCO $13.76
  • XENE $26.74
  • 52 Week High
  • VSCO $48.73
  • XENE $44.61
  • Technical
  • Relative Strength Index (RSI)
  • VSCO 60.80
  • XENE 49.07
  • Support Level
  • VSCO $34.00
  • XENE $37.72
  • Resistance Level
  • VSCO $39.01
  • XENE $39.41
  • Average True Range (ATR)
  • VSCO 1.79
  • XENE 1.54
  • MACD
  • VSCO -0.21
  • XENE -0.36
  • Stochastic Oscillator
  • VSCO 40.10
  • XENE 43.69

About VSCO Victorias Secret & Co.

Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: